Stocks to buy

Detroit’s comeback is nothing short of a miracle. As a city, it was dead and buried as recently as 2013, when it declared bankruptcy with more than $18 billion in debt. It has come a long way since those dark days. It’s not perfect — no city is. However, it’s attracting attention from various places,

Every once in a while, a company may undergo a rough period financially or take a hit to its public perception. Sometimes, these maladies can persist quarter after quarter, and cause the company’s stock to tank. It’s important to remember, however, that so long as the company does not financially collapse or cease to exist,

Wedbush Securities has a solid track record with many publicly traded companies it covers. Over the past few months, the investment firm hiked its price target on several intriguing companies, many of which may prove great buys after the recent wave of market volatility. Of course, investors shouldn’t treat any analyst rating and price targets

Healthcare stocks certainly haven’t set the world on fire lately. The S&P Health Care Index is up 3% so far in 2024 compared to an 8% gain in the benchmark S&P 500. Yet, many leading healthcare companies just issued better-than-expected financial results for this year’s first quarter. Additionally, these stocks tend to perform well during

May has brought attention to seven penny stocks that investors should consider adding to their portfolios. As a keen observer of the cryptocurrency market, I’ve been watching Bitcoin (BTC-USD) closely as it aims to reach new all-time highs. However, I’ve also been keeping an eye on some fascinating penny stocks that I believe offer significant

Sometimes a company’s debut or the release of a new product can stir analysts into a frenzy. Other times, careful consideration of long-term trends and performance can drive improved public opinion of a company’s prospects. In such cases, the resulting market conditions offer stocks with analyst recommendations that simply cannot be ignored. That’s because the

The recent economic reports have raised concerns about a potential negative future for the United States economy, characterized by stagflation—a troubling situation of rising inflation and slowing economic growth. The latest GDP figures showed a significant slowdown in growth, with the economy expanding at only 1.6% annually, well below expectations. Concurrently, measured by personal consumption

In today’s investment landscape, discerning potential in stocks from various industries requires a nuanced understanding of sector-specific innovations and market demands. The first stock operating in electronics manufacturing benefits from a surge in global demand for advanced consumer electronics and integrated supply chain solutions.  The second thrives in AI and data analytics, witnessing transformative growth. The

For the past several weeks, stocks have been caught in rough waters. After the most recent batch of hotter-than-expected inflation data sent investors spiraling into panic mode, Federal Reserve rate-cut hopes evaporated. Yields rocketed; and stocks dropped. In fact, Wall Street has been holding its breath since that data’s release, eagerly awaiting the Fed’s next

Penny stocks are on the riskier end of the public equity spectrum. They are characterized by their low volume, affordable pricing, and the rapid pace at which their values can surge or plummet compared to more traditional stocks. But, for well-informed investors, penny stocks offer a chance to secure substantial gains on the cheap. When

The Dow Jones Industrial Average has been around since 1885. The index contains 30 stocks and has regularly added and removed holdings from the list. An index with 30 stocks has more concentration than indices like the S&P 500 and the Nasdaq 100, which spread their assets across more holdings. However, some Dow stocks to buy are better than others. Investors must

Biotech stocks are full of intriguing innovators who could help pave the way for greater gains over the years ahead. Undoubtedly, it’s virtually impossible to tell exactly which pills, shots and treatments within a firm’s pipeline will eventually evolve into cash flows, let alone blockbuster cash cows. With many clinical trials to pass, even a

While a weakening economy and a subsequent dip in the stock market are unfortunate, they are inevitabilities. Even booming segments like the biotech sector are not immune to the general trend of recessions that Western economies experienced over the last 40 years or so. These downturns, however, provide opportunities for investors to buy stocks at

It’s not all fun and games when it comes to the market’s top spatial computing (or metaverse) stocks. Undoubtedly, we’ve seen some pretty capable mixed-reality headsets launching in recent years. And with the launch of Apple (NASDAQ:AAPL) Vision Pro, it seems like mixed reality isn’t all too far off from making its mark on the

Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks. Each exhibits unique approaches and accomplishments in biotechnology, healthcare services, and pharmaceuticals. Solid product leads, especially in the U.S. market, have propelled the first company’s biosimilar industry to an astounding rise.

Alphabet’s (NASDAQ:GOOG, NASDAQ:GOOGL) Gemini AI has once again been overtaken by other models, but it remains one of the best choices out there for AI stock predictions. Bard (the company’s model preceding Gemini) was previously ranked by analysts as the best AI tool for stock picking, even outperforming human stock pickers a test run. However, Gemini has

When the going gets tough, the tough buy blue chip stocks. That’s because they are safe havens in times of turmoil. These are large companies with a proven track record of success and profits that have sterling financial statements. That means when markets go south, they will continue standing tall. The following three blue chip

The average investor probably appreciates no-hassle investments more than anything else. Most investors simply want to set it and forget it when it comes to their portfolio. Far fewer investors are willing or capable of spending their time tethered to trading stations in an attempt to find Alpha. That’s part of the reason blue-chip stocks

Once a Wall Street darling, Netflix (NASDAQ:NFLX) is now considered a left-behind as the market obsesses over Magnificent Seven stocks. Nowadays, positive earnings results aren’t enough to get investors enthused about Netflix stock. Yet, today you can be a leader instead of a follower. I invite you to contravene the crowd, embrace change and build a

PayPal (NASDAQ:PYPL) is favored in the current market. Despite slowing user growth, it remains profitable with consistent 8% revenue growth, and earnings continue to expand at a rapid pace (up 27% this past quarter). Wall Street continues to overlook PayPal’s strengths, focusing on temporary user decline rather than the strong numbers the company has put